Hypertension is a major risk factor for cardiovascular and cerebrovascular diseases.
| INTRODUC TI ON
Chronic elevation of blood pressure (BP), a complex disorder is a major global health issue. Hypertension is a major risk factor for cardiovascular and cerebrovascular disease, 1 and accounts for approximately 45% of cardiovascular disease mortality and morbidity worldwide. 2 The goal of hypertension management is not only to reduce BP but also to prevent end-organ damage and maintain vascular integrity. The importance of decreasing and adequately controlling BP throughout each 24-hour period for reducing mortality and morbidity cannot be overemphasized. BP shows circadian variation, being higher during the day (or awake periods) and lower at night (or during sleep). In addition, cardiovascular events are more likely to occur in the morning. [3] [4] [5] [6] [7] [8] It has been suggested that extreme BP variability (BPV) results in large dynamic surges triggering adverse cardiovascular events (the resonance hypothesis) and that cardiovascular risk is particularly exaggerated in high-risk patients with vascular disease. 9 One important phenotype of BPV is the early morning blood pressure surge (EMBS), which probably contributes to the high rate of cardiovascular events occurring at that time of day.
The systemic hemodynamic atherothrombotic syndrome (SHATS), a concept proposed by Kario and colleagues, is a vicious cycle of hemodynamic stress and vascular disease that advances organ damage and triggers cardiovascular disease. 10 Clinical phenotypes of SHATS include large-artery atherothrombotic diseases (such as stroke, coronary artery disease, and aortic and peripheral artery disease), heart failure, small-artery disease, and microcirculation-related disease (such as chronic kidney disease and retinopathy). Appropriate detection of BP and BPV, and the early detection and management of SHATS, should facilitate more effective individualized cardiovascular protection.
| MORNING B LOOD PRE SSURE SURG E
Morning BP surge is a normal physiological phenomenon of circadian or diurnal BPV. It has been defined as the difference between morning BP (measured 2 hours after awakening) and the lowest night-time BP (Figure 1 ). 6 High morning surge may lead to target organ damage such as left ventricular hypertrophy and left ventricular mass index (LVMI), 11 arterial stiffness and carotid atherosclerosis, [12] [13] [14] [15] and renal albuminuria. 16 In addition, exaggerated EMBS surge is associated with other adverse cardiovascular 5, 6 and cerebrovascular events, especially hemorrhagic stroke. 6, 8, 17 
| B LOOD PRE SSURE VARIAB ILIT Y
Variability is an intrinsic property of BP, and is essential for physiological adaptability. BPV can be spontaneous and is especially striking during physical activity, anxiety and emotional episodes. The concept of BPV is not new and was recognized in the early 1970s, with an editorial by James Conway noting that "The diagnosis of hypertension has always been bedeviled by variability in blood pressure." 18 In a simple sense, BPV can be defined as the average variation of BP throughout the day, quantified as the standard deviation (SD) of ambulatory blood pressure monitoring (ABPM) recordings. There are circadian, short-term and long-term components to BPV. Diurnal BPV refers to day-to-night changes in BP. There is also temporal variability in BP with age due to arteriosclerosis and variability due to differences between central and peripheral arteries. As a result, BPV may need to be confirmed using a variety of measures, including beat-to-beat assessment, multiple manual or digital recordings, and home and/or ambulatory blood pressure monitoring. Table 1 summarizes the different indices used to assess BPV.
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Differences in hypertension and related cardiovascular disease rates have been reported between Western and Asian populations, including a higher rate of stroke, higher prevalence of metabolic syndrome, greater salt sensitivity and more common high morning and nocturnal BP readings in Asians. This highlights a need for BP management strategies that take into account ethnic differences. In general, long-acting antihypertensives that control BP throughout the 24-hour period are preferred; amlodipine and telmisartan have been shown to control EMBS more effectively than valsartan. Home and ambulatory BP monitoring should form an essential part of hypertension management, with individualized pharmacotherapy to achieve optimal 24-hour BP control particularly the EMBS and provide the best cardio-and cerebrovascular protection. Future research should facilitate better understanding of BPV, allowing optimization of strategies for the detection and treatment of hypertension to reduce adverse outcomes.
| Factors affecting blood pressure variability
Available data indicate that ethnicity, age, sex, body mass index, socioeconomic status, a sedentary lifestyle, diabetes mellitus, history of hypertension, cardiovascular disease, renal disease, and use of drugs such as beta-blockers are some of the important factors associated with BPV ( Table 2 ). [19] [20] [21] [22] Even environmental pollution can have an effect on BPV according to a recent study. 23 
| Clinical manifestations of blood pressure variability
The intrinsic variability in BP can make accurate diagnosis of hypertension difficult, particularly when based on individual BP readings.
Use of 24-hour ABPM along with routine clinic or hospital recordings can help to accurately and reliably diagnose true hypertension.
Using this approach, patients can be categorized into four groups In the context of BPV, a new way of looking at white coat hypertension could be described as increased BPV with normal F I G U R E 1 Derivation of the morning blood pressure surges from 24-hour ambulatory blood pressure recordings. The sleep-trough morning surge is the difference between the morning pressure and the lowest night-time blood pressure. The pre-awakening morning surge is the difference between the morning blood pressure and the pre-awakening blood pressure (From: Ref. 1 70 Weighted SD is the difference between MMD (maximum minus minimum BP) and ARV (average real variability). These were measured by ABPM and represent the mean of day and night SD values weighted for the number of hours covered by these two periods. ARV is the average of the absolute differences between consecutive readings, weighted for the between-reading time intervals and accounting for the order of the BP recordings
Weighted SD also depends on the BP level
Variability independent of the mean (VIM)
Rothwell et al 34 VIM is the within-subject SD derived from the within-subject mean BP to the power of x and multiplied by the population mean BP to the power x (the power x is obtained by fitting a curve through a plot of SD against mean BP level, using a model where SD = a × mean x , where x is derived by non-linear regression)
VIM correlated best with indices and outcomes associated with BPV, rather than BP ABPM, ambulatory blood pressure monitoring; BP, blood pressure; BPV, blood pressure variability.
out-of-office BP, and masked hypertension could be described as increased BPV and elevated out-of-office BP. 24 From a therapeutic perspective, white coat hypertension is considered to be benign, but the detection of masked hypertension is essential because it is associated with significantly increased cardiovascular risk if undetected. 25 However, data from the Spanish ABPM registry suggest that white coat hypertension may not in fact be a benign condition. 26 
| B LOOD PRE SSURE VARIAB ILIT Y AND MORNING B P SURG E

| The synergistic resonance hypothesis
The circadian rhythm of normal BP is controlled by various neurohumoral factors. Activation of the sympathetic autonomic nervous system and suppression of vagal tone elevates BP on awakening. [27] [28] [29] At the same time, other hemodynamic parameters, including heart rate, vasomotor tone, and blood viscosity, are increased. 29, 30 Significantly elevated plasma epinephrine levels, posture-related sympathetic neural reflexes, 27 and early morning release of renin and angiotensin II, 31 may all contribute to morning surges. Daytime physical activity is the main factor responsible for elevating BP during periods of wakefulness. Other factors affecting BPV are summarized in Table 3 .
As per the synergistic resonance hypothesis proposed by Kario et al, 9 the EMBS can be potentiated by synergistic resonance of a variety of other BPV components that contribute to increased cardiovascular risk. [32] [33] [34] These include beat-by-beat, visit-to-visit, orthostatic, diurnal, seasonal, annual, and physical or psychological stress-induced BPV.
High-risk patients with advanced vascular disease are at increased risk of adverse cardiac and stroke events. BPV and related hemodynamic stress in the setting of diseased macro-and microvasculature contributes to a vicious cycle resulting in end-organ damage and SHATS. 32 Exaggerated or abnormal BPV is also associated with more rapid progression of left ventricular mass index (LVMI) and increased carotid intima-medial thickness. 14 This was found to be an independent predictor of cerebrovascular events 34 and was a stronger predictor than mean BP and day-night variability in BP. 38 Hemodynamic factors associated with BPV based on ABPM were recently investigated. 39 The hemodynamic variable that showed the most significant independent association with diastolic BP average real variability (ARV) on ABPM was arterial pulse wave reflection. 39 Elevation of inflammatory markers such as C-reac- 
| Cardiovascular risk
There is significant evidence for a relationship between both BPV and EMBS and increased rates of adverse cardiovascular events, renal decline, and end-organ damage. 40, 41 It appears that BPV and cardiovascular risk may have a U-shaped curve relationship, which is even more marked among patients with hypertension than those with normal BP. 32 Thus, both lack of BPV and exaggerated BPV appear to be pathological. 38 A number of epidemiological studies have documented a strong association between the timing of cardiovascular event onset and the circadian variation in BP. [3] [4] [5] [6] [7] [8] It has also been shown that abnormal circadian BPV with non-dipping pattern increases the risk of having a stroke event. 42 In elderly hypertensive patients, Kario et al were first to demonstrate that exaggerated EMBS measured using ABPM was independently associated with stroke risk. 6 Specifically, the risk of future stroke was 2.7 times higher in patients who were in the top decile of morning BP surge (≥55 mm Hg) compared with those whose morning surge was <55 mm Hg. 6 Pierdominico and colleagues found that in addition to coronary events, stroke was also associated with exaggerated EMBS, independent of 24-hour BP. 17 There was a 24% increase in stroke risk for each 10 mm Hg increase in EMBS (P = 0.004). 17 Data from meta-analyses showed that EMBS was associated with higher relative risks for stroke (49%), myocardial infarction (40%), and sudden cardiac death (29%). 43, 44 The
International Database in Ambulatory BP monitoring in relation to Cardiovascular Outcomes (IDACO) study found that both daytime and nocturnal blood pressure monitoring provided valuable prognostic information, stating that even isolated nocturnal rise of BP in normotensives and normal daytime BP recordings predict cardiovascular outcomes. 45 Table 4 summarizes six important studies using ABPM to investigate associations between the EMBS and cardiovascular events.
| Controversies
There is a reasonable body of evidence for the association between abnormal BPV and EMBS and higher rates of adverse cardiac and cerebrovascular outcomes, including mortality. However, there is still some disagreement about the prognostic significance of BPV and EMBS. 32, 46 In the large International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcome (IDACO) study, exaggerated EMBS was independently associated with cardiovascular, but not non-cardiovascular, death. 7 This may be because the patient population in IDACO was younger than that enrolled in some other studies. 6, 17 A study from Denmark that included 100 patients with newly detected diabetes used ABPM to study EMBS and the systolic night-day ratio (SND). 47 In hypertensive patients, these parameters have been associated with a higher rate of cardiovascular events. However, the Danish study did not show any association between EMBS and SND and subclinical markers of early vascular target organ damage, including pulse wave velocity (PWV), white matter lesions (WML) on brain magnetic resonance imaging (MRI), and urine-albumin creatinine ratio (UAE). In a cohort of 3012 patients with untreated hypertension, Verdecchia et al reported that although a blunted sleep-trough and pre-awakening BP surge were associated with an excess risk of major cardiovascular events, there was no corresponding increase in mortality risk. 48 The results of a Systolic Hypertension in Europe (Syst-Eur) trial substudy suggested that BP-lowering therapy reduced cardiovascular complications by decreasing systolic BP rather than BPV and that it is the absolute value of systolic BP that predicts risk than variability indices. 49 Thus, published data indicate that BPV definitions and terminology are inconsistent between studies, and the fact that BPV values have poor reproducibility might contribute to conclusions that BPV is only a weak predictor of cardiovascular risk. 5, 7, 8, 47, 50 The validity of the recordings, the predictability of variability indices, and the confounding effects of timing of antihypertensive medication intake all need to be considered when evaluating available evidence. Some authors suggest that EMBS could be an epiphenomenon of BPV and that it may represent only a part of 24-hour BPV. 50
| E VIDEN CE FROM A S IA
Geographical location, race, and ethnicity are well-recognized factors influencing the prevalence of hypertension. Differences in the rates of hypertension and related cardiovascular diseases have been reported between Western and Asian populations. Specific differences include the following:
1. Stroke (especially hemorrhagic stroke) is more common than myocardial infarction in Asians;
Asians show a steeper association between BP and cardiovascular disease;
3. Asians have higher salt intake than Westerners, leading to higher salt sensitivity;
4. There is a high prevalence of obesity and metabolic syndrome in Asia;
5. High morning and nocturnal BP readings are more common in Asians. TA B L E 4 (Continued) (P ≤ 0.03), and circadian BPV (P < 0.01) were associated with EMBS. 51 In a study of 340 patients from China, the proportion of subjects with EMBS was higher in patients with hypertension compared with normotensive participants. 52 In addition, daytime SBP was the best predictor of the rate of morning surge in SBP, and EMBS was associated with cardiovascular and stroke events. 52
| China
| Japan
The Jichi Medical University-Ambulatory Blood Pressure Monitoring (JMU-ABPM) study investigated the association between the time of onset of events and morning BP surge. The results showed that the incidence of stroke events in the morning hours was higher in subjects with exaggerated morning BP surge than in those without exaggerated morning BP surge (Table 4 ). 6 Hoshide et al showed that 
| India
The incidence of hypertension, diabetes, and cardiovascular disease burden in India is rapidly increasing. However, there are few large-scale studies on BPV and EMBS in the Indian population.
One study in 122 consecutive patients with diabetes showed that poor glycemic control and insulin resistance predicted the occurrence of morning BP surge. 55 Sultana et al studied the role of genetic factors in BPV among the Kumba community from the state of Chattisgarh, India. 56 The study compared members of two families consisting of three to four generations which showed significant differences in 24-hour mean BP values, BPV, and nocturnal dipping in systolic BP. 56
| Taiwan
The prognostic value of long-term BPV was studied in a Taiwanese community-based population (n = 1257) using ABPM. 57 The popu- Based on the pathophysiological basis that morning BP surge may be related to activation of the sympathetic nervous system and renin-angiotensin-aldosterone system (RAAS), it would be logical to use drugs that have mechanisms of action involving these pathways. However, the best clinical evidence comes from the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure
Lowering Arm (ASCOT-BPLA), which included ambulatory BP recordings in 1905 high-risk hypertensive patients. 67 The results
showed that amlodipine was more effective than atenolol for controlling nocturnal BP due to its longer duration of action. Available evidence suggests that it is appropriate to consider home and ambulatory BP monitoring as an essential part of hypertension assessment, and to tailor pharmacotherapy to achieve optimal 24hour BP control and therefore maximize the benefits of treatment with respect to mitigation of cardio-and cerebrovascular disease risk.
| CON CLUS ION
Systemic hypertension is a major modifiable cardiovascular risk factor. BPV and EMBS are important hypertension biomarkers and significant, independent predictors of adverse cardiovascular events and SHATS. Single clinic or office BP readings may underestimate both the prevalence and severity of hypertension and associated risks. Ideally, beat-to-beat continuous monitoring is the best way to assess hypertension and BPV, and the EMBS is a simple and predictable measure of BPV. Systemic hypertension and associated risks have a multifactorial etiology, including intrinsic neurohumoral factors (eg, the RAAS) and
